Trials / Completed
CompletedNCT01851850
Continuation Treatment Protocol for Patient Who Participated in the BIA 9-1067-302 Clinical Trial
Continue Providing Care for Patient Who Participated in the BIA 9-1067-302 Clinical Trial
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 1 (actual)
- Sponsor
- Rabin Medical Center · Academic / Other
- Sex
- All
- Age
- 30 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to extend the use of opicapone 25 or 50mg once per day by subjects who participated in the BIA 9-1067-302 clinical trial according form 4a for additional three years.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Opicapone | 25mg or 50mg once per day |
Timeline
- Start date
- 2013-05-01
- Primary completion
- 2016-05-24
- Completion
- 2016-05-24
- First posted
- 2013-05-13
- Last updated
- 2020-03-16
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT01851850. Inclusion in this directory is not an endorsement.